Literature DB >> 32016946

CSN6: a promising target for cancer prevention and therapy.

Jianbing Hou1,2,3, Hongjuan Cui2,3,4.   

Abstract

CSN6 has recently received increased attention as a multifunctional protein involved in protein stability. CSN6 plays an important role in controlling cellular proliferation, apoptosis and metastasis, modulating signal transduction, as well as regulating DNA damage and repair. Most studies have demonstrated that CSN6 is significantly upregulated in human malignant tumors such as cervical cancer, papillary thyroid cancer, colorectal cancer, breast cancer, lung adenocarcinoma, and glioblastoma, and its expression is usually correlated with poor prognosis. In this review, we summarize recent available findings regarding the oncogenic role of CSN6 in tumors, and provide a better understanding of CSN6 function at the molecular level and its potential therapeutic implications in combating human cancers.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32016946     DOI: 10.14670/HH-18-206

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  55 in total

1.  Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.

Authors:  Hyun Ho Choi; Sergei Guma; Lekun Fang; Liem Phan; Cristina Ivan; Keith Baggerly; Anil Sood; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

2.  COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.

Authors:  H H Choi; C Gully; C-H Su; G Velazquez-Torres; P-C Chou; C Tseng; R Zhao; L Phan; T Shaiken; J Chen; S C Yeung; M-H Lee
Journal:  Oncogene       Date:  2011-05-30       Impact factor: 9.867

3.  Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.

Authors:  Eric J Bennett; John Rush; Steven P Gygi; J Wade Harper
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

Review 4.  Structure and function of MPN (Mpr1/Pad1 N-terminal) domain-containing proteins.

Authors:  Melissa Birol; Aude Echalier
Journal:  Curr Protein Pept Sci       Date:  2014       Impact factor: 3.272

5.  CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.

Authors:  Bo Chen; Ruiying Zhao; Chun-Hui Su; Monica Linan; Chieh Tseng; Liem Phan; Lekuan Fang; Heng-Yin Yang; Huiling Yang; Wenqian Wang; Xiaoyin Xu; Nan Jiang; Shouliang Cai; Feng Jin; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

6.  CSN6-COP1 axis in cancer.

Authors:  Hyun Ho Choi; Mong-Hong Lee
Journal:  Aging (Albany NY)       Date:  2015-07       Impact factor: 5.682

7.  CSN6 drives carcinogenesis by positively regulating Myc stability.

Authors:  Jian Chen; Ji-Hyun Shin; Ruiying Zhao; Liem Phan; Hua Wang; Yuwen Xue; Sean M Post; Hyun Ho Choi; Jiun-Sheng Chen; Edward Wang; Zhongguo Zhou; Chieh Tseng; Christopher Gully; Guermarie Velazquez-Torres; Enrique Fuentes-Mattei; Giselle Yeung; Yi Qiao; Ping-Chieh Chou; Chun-Hui Su; Yun-Chih Hsieh; Shih-Lan Hsu; Kazufumi Ohshiro; Tattym Shaikenov; Huamin Wang; Sai-Ching Jim Yeung; Mong-Hong Lee
Journal:  Nat Commun       Date:  2014-11-14       Impact factor: 14.919

Review 8.  The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis.

Authors:  Patrick A Carroll; Brian W Freie; Haritha Mathsyaraja; Robert N Eisenman
Journal:  Front Med       Date:  2018-07-27       Impact factor: 4.592

Review 9.  HPV E6, E6AP and cervical cancer.

Authors:  Sylvie Beaudenon; Jon M Huibregtse
Journal:  BMC Biochem       Date:  2008-10-21       Impact factor: 4.059

10.  COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.

Authors:  Hyun Ho Choi; Liem Phan; Ping-Chieh Chou; Chun-Hui Su; Sai-Ching J Yeung; Jiun-Sheng Chen; Mong-Hong Lee
Journal:  Oncotarget       Date:  2015-08-14
View more
  1 in total

1.  CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.

Authors:  Yanli Zhang; Jianbing Hou; Shaomin Shi; Juan Du; Yudong Liu; Pan Huang; Qian Li; Lichao Liu; Huanrong Hu; Yacong Ji; Leiyang Guo; Yaqiong Shi; Yaling Liu; Hongjuan Cui
Journal:  Cell Death Dis       Date:  2021-01-22       Impact factor: 8.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.